These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8075776)

  • 21. Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS.
    Ros JJ; Pelders MG; Egberts AC
    J Anal Toxicol; 1998; 22(1):40-4. PubMed ID: 9491967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of drugs of abuse in blood.
    Moeller MR; Steinmeyer S; Kraemer T
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):91-109. PubMed ID: 9700554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hybrid liquid chromatography-mass spectrometry strategy in a forensic laboratory for opioid, cocaine and amphetamine classes in human urine using a hybrid linear ion trap-triple quadrupole mass spectrometer.
    Dowling G; Regan L; Tierney J; Nangle M
    J Chromatogr A; 2010 Oct; 1217(44):6857-66. PubMed ID: 20855077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of freezing on the concentration of drugs of abuse in urine.
    Paul BD; McKinley RM; Walsh JK; Jamir TS; Past MR
    J Anal Toxicol; 1993 Oct; 17(6):378-80. PubMed ID: 8271786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the ion-trap mass spectrometer for routine qualitative and quantitative analysis of drugs of abuse extracted from urine.
    Vorce SP; Sklerov JH; Kalasinsky KS
    J Anal Toxicol; 2000 Oct; 24(7):595-601. PubMed ID: 11043665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium.
    ElSohly MA; Stanford DF; Murphy TP; Lester BM; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HC
    J Anal Toxicol; 1999 Oct; 23(6):436-45. PubMed ID: 10517548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine drug testing for social service agencies in Nova Scotia, Canada.
    Fraser AD
    J Forensic Sci; 1998 Jan; 43(1):194-6. PubMed ID: 9456542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs of abuse monitoring in blood for control of driving under the influence of drugs.
    Moeller MR; Kraemer T
    Ther Drug Monit; 2002 Apr; 24(2):210-21. PubMed ID: 11897967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of full-scanning GC/ion trap MS analysis of NIDA drugs-of-abuse urine testing in urine.
    Wu AH; Onigbinde TA; Wong SS; Johnson KG
    J Anal Toxicol; 1992; 16(3):202-6. PubMed ID: 1522718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new mixed mode solid phase extraction strategy for opioids, cocaines, amphetamines and adulterants in human blood with hybrid liquid chromatography tandem mass spectrometry detection.
    Dowling G; Regan L
    J Pharm Biomed Anal; 2011 Apr; 54(5):1136-45. PubMed ID: 21194869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aqueous phase hexylchloroformate derivatization and solid phase microextraction: determination of benzoylecgonine in urine by gas chromatography-quadrupole ion trap mass spectrometry.
    Hall BJ; Parikh AR; Brodbelt JS
    J Forensic Sci; 1999 May; 44(3):527-34. PubMed ID: 10408106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of drugs used in cases of alleged sexual assault.
    ElSohly MA; Salamone SJ
    J Anal Toxicol; 1999; 23(3):141-6. PubMed ID: 10369321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a human on-site urine multidrug test for emergency use with dogs.
    Teitler JB
    J Am Anim Hosp Assoc; 2009; 45(2):59-66. PubMed ID: 19258416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS.
    Feng J; Wang L; Dai I; Harmon T; Bernert JT
    J Anal Toxicol; 2007 Sep; 31(7):359-68. PubMed ID: 17725883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.